Treatment of acute and chronic respiratory diseases accompanied by violation of bronchial secretion and evacuation of secretions : including acute and chronic bronchitis, chronic obstructive pulmonary diseases, pneumonia, bronchiectatic disease, bronchial asthma, cystic fibrosis, laryngitis, tracheitis.
Pulmolor Composition and form of release
Active ingredient: ambroxol hydrochloride – 60 mg, loratadine – 5 mg.
Pulmolor is produced in the form of tablets, powder for suspension preparation.
It is an expectorant, phlegm-thinning medicine. It dilutes the viscous secretion of the bronchi, facilitates its discharge by improving mucociliary clearance (movement of mucus produced by ciliated cells). It also improves the performance of external respiration, acting as an expectorant (an agent promoting the excretion of phlegm) and a mucolytic (a thinning agent). Increases the amount of surfactant (a substance that prevents the collapse of the alveoli). Also has antiallergic effect.
Pulmolor is prescribed for chronic or acute diseases of the respiratory organs, accompanied by viscosity of sputum, difficult discharge of it:
- with bronchitis;
- with bronchiectasis;
- with laryngitis;
- with tracheitis;
- with pharyngitis;
- with sinusitis;
- with rhinitis (runny nose), incl. allergic;
- with pneumonia;
- with bronchial asthma;
- with cystic fibrosis of the lungs;
- with respiratory distress syndrome (shock lung);
- for the treatment / prevention of lung complications after surgery;
- during preparation for bronchoscopy.
Pulmolor should not be used:
- with severe impairment of the kidneys / liver;
- with allergies, intolerance to the components of this medication;
- With caution, Pulmolor is used for peptic ulcer disease or erosion of the stomach / intestine, while taking antitussive pharmaceuticals.
It is prescribed for children from 12 years old (tablets), from 6 years old (suspension).
Application during pregnancy and lactation
Active molecules are able to penetrate the protective placental barrier. However, animal studies have not shown a negative impact on the development of the embryo (fetus), pregnancy / childbirth. However, precautions should be taken when taking the medication during pregnancy.
The drug Pulmolor is not recommended for the treatment of mothers during breastfeeding.
Method of administration and dosage
For adult patients, Pulmolor is prescribed orally (by mouth) after meals.
Adults, children from 12 years old are prescribed 1 tablet *2 times / day.
Therapy should only be carried out under medical supervision.
Pulmolor should not be used for more than 14 days.
Symptoms: tachycardia, drowsiness, stool disorders (constipation or diarrhea), nausea, other dyspeptic symptoms, drop in blood pressure.
Overdose treatment: it is required to immediately (in the first hours after taking the medicine) rinse the stomach or artificially induce vomiting, conduct symptomatic therapy.
- Digestive disorders: dry mouth, diarrhea (loose stools), nausea, heartburn, constipation, gastralgia (pain in the supra-gastric region), salivation, liver dysfunction.
- Cardiac disorders: palpitation, tachycardia.
- Allergic reactions: contact dermatitis, angioedema Quincke (rapidly developing edema of the lips, face, larynx), urticaria, skin rashes, itching, anaphylactic type reactions (including shock).
- Neurological disorders: dysgeusia (taste disorder), seizures, dizziness, headaches, nervousness, drowsiness, fatigue, insomnia.
- Others: weakness, headache, alopecia, rhinorrhea, dysuria, fever, increased appetite.
Storage conditions and periods
At 15-25 ° С. Shelf life Pulmolor is 3 years. After preparation, the suspension should be stored no more than 14 days at 2–8 ° С.